J. Mayhew
Ultragenyx Pharmaceutical (United States)(US)
Publications by Year
Research Areas
Muscle Physiology and Disorders, Glycogen Storage Diseases and Myoclonus, Lysosomal Storage Disorders Research, Neurogenetic and Muscular Disorders Research, Child Nutrition and Feeding Issues
Most-Cited Works
- → A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease(2010)737 cited
- → Enzyme-Replacement Therapy in Life-Threatening Hypophosphatasia(2012)559 cited
- → Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children(2001)249 cited
- → Clinical features of late‐onset Pompe disease: A prospective cohort study(2008)172 cited
- → Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy(2011)161 cited
- → Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy(2006)120 cited
- → CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy(2005)107 cited
- → UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24 weeks of treatment(2017)78 cited
- → CINRG pilot trial of coenzyme Q10 in steroid‐treated duchenne muscular dystrophy(2011)50 cited
- → Pentoxifylline as a rescue treatment for DMD(2012)25 cited